You are here » Home » Companies » Company Overview » Hester Biosciences Ltd

Hester Biosciences Ltd.

BSE: 524669 Sector: Health care
NSE: HESTERBIO ISIN Code: INE782E01017
BSE 15:40 | 22 Feb 1577.80 -24.75
(-1.54%)
OPEN

1605.00

HIGH

1611.85

LOW

1574.05

NSE 15:31 | 22 Feb 1585.85 -23.35
(-1.45%)
OPEN

1598.65

HIGH

1630.00

LOW

1575.00

OPEN 1605.00
PREVIOUS CLOSE 1602.55
VOLUME 26
52-Week high 1949.80
52-Week low 716.00
P/E 46.83
Mkt Cap.(Rs cr) 1,343
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 1605.00
CLOSE 1602.55
VOLUME 26
52-Week high 1949.80
52-Week low 716.00
P/E 46.83
Mkt Cap.(Rs cr) 1,343
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Hester Biosciences Ltd. (HESTERBIO) - Company History

Incorporated as a private limited company in Apr.'87, Hester Pharmaceutical (HPL) was converted into a public limited company in Nov.'93. HPL markets and distributes veterinary and pharmaceutical products like animal health products, poultry vaccines, poultry diagnostic, laboratory kits and reagents. It markets the veterinary products of many international companies including Ghen Corporation, Japan; Maine Biological Laboratories, US; Idexx Corporation, US; International Diagnostic Systems Corporation, US; Biogal Galed Laboratories, Israel; and Kemin Europa, Belgium. The company's own production of veterinary vaccines (in Vials) is expected to commence soon. HPL has technical collaborations with Maine Biological Laboratories and Ghen Corporation. During 1996-97, company successfully implemented veterinary vaccine and commercial production has begun. The company has received licenses for producing 10 additional poultry vaccines.It has also signed an manufacturing agreement with Sinsui Inc for producing poultry vaccines.